MARKET

PDSB

PDSB

Pds Biotechnology Corporation
NASDAQ
0.8700
-0.0241
-2.70%
After Hours: 0.8500 -0.02 -2.30% 16:56 12/05 EST
OPEN
0.8900
PREV CLOSE
0.8941
HIGH
0.9132
LOW
0.8342
VOLUME
379.65K
TURNOVER
--
52 WEEK HIGH
2.460
52 WEEK LOW
0.7030
MARKET CAP
45.57M
P/E (TTM)
-1.0619
1D
5D
1M
3M
1Y
5Y
1D
PDS Biotechnology Gains FDA Meeting for PDS0101 Approval
TipRanks · 4d ago
PDS Biotechnology announces request for Type C Meeting with FDA for PDS0101
TipRanks · 4d ago
PDS BIOTECHNOLOGY CORP - MEETING TO DISCUSS ACCELERATED APPROVAL FOR PDS0101
Reuters · 4d ago
Weekly Report: what happened at PDSB last week (1124-1128)?
Weekly Report · 5d ago
PDS Biotechnology Price Target Cut to $3.00/Share From $5.00 by B. Riley Securities
Dow Jones · 11/25 18:24
PDS Biotechnology Is Maintained at Buy by B. Riley Securities
Dow Jones · 11/25 18:24
B. Riley Securities Maintains Buy on PDS Biotechnology, Lowers Price Target to $3
Benzinga · 11/25 18:14
PDS Biotechnology price target lowered to $3 from $5 at B. Riley
TipRanks · 11/25 13:40
More
About PDSB
PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused antibody drug conjugate (ADC), PDS01ADC, a tumor targeting immunocytokine. PDS0101 is its lead Versamune based immunotherapy. PDS0101 combines Versamune with a mixture of short proteins (peptides) derived from the cancer-causing HPV16 viral protein. Versamune is a proprietary lipid nanoparticle and T cell activating platform. PDS0301 is an investigational tumor-targeting antibody conjugate of Interleukin 12 (IL-12) that enhances the proliferation, potency, infiltration, and longevity of T cells in the tumor microenvironment. Its Versamune immunotherapies and Versamune in combination with PDS01ADC, are utilized for treatments in oncology, and Infectimune is utilized for preventive vaccines against infectious agents.

Webull offers PDS Biotechnology Corp stock information, including NASDAQ: PDSB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PDSB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PDSB stock methods without spending real money on the virtual paper trading platform.